These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1703925)

  • 1. Phospholipase C treatment of certain human target cells reduces their susceptibility to NK lysis without affecting binding or sensitivity to lytic granules.
    Une C; Grönberg A; Axberg I; Jondal M; Orn A
    Cell Immunol; 1991 Mar; 133(1):127-37. PubMed ID: 1703925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased natural killer (NK) susceptibility of human NK target cells after phosphatidylinositol-specific phospholipase C treatment.
    Uggla C; Une C; Axberg I; Jondal M; Knowles RW; Orn A
    Scand J Immunol; 1989 Jan; 29(1):83-9. PubMed ID: 2537997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
    J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma-treated K562 target cells distinguish functional NK cells from lymphokine-activated killer (LAK) cells.
    Powell J; Stone J; Chan WC; Yang ZD; Leatherbury A; Sell KW; Wiktor-Jedrzejczak W; Ahmed-Ansari A
    Cell Immunol; 1989 Feb; 118(2):250-64. PubMed ID: 2491960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
    Uchida A; Klein E
    Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular localization and functional role of phosphatidylcholine-specific phospholipase C in NK cells.
    Ramoni C; Spadaro F; Menegon M; Podo F
    J Immunol; 2001 Sep; 167(5):2642-50. PubMed ID: 11509606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
    J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y; Bonavida B; Nio Y; Yoshida O
    Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon and butyrate treatment leads to a decreased sensitivity of NK target cells to lysis by homologous but not by heterologous effector cells.
    Laskay T; Kiessling R
    Nat Immun Cell Growth Regul; 1986; 5(4):211-20. PubMed ID: 3095635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K562 cells induced to differentiate by phorbol ester tumor promotors resist NK lysis.
    Dokhelar MC; Garson D; Wakasugi H; Tabilio A; Testa U; Vainchenker W; Tursz T
    Cell Immunol; 1984 Sep; 87(2):389-99. PubMed ID: 6205768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the susceptibility to NK-mediated lysis and the simultaneous expression of various surface molecules in anthracyclin-treated K562 cells and in four K562 cell clones.
    Benoist H; Joly P; Broglio C; Jeannesson P; Idoine O; Dufer J; Desplaces A
    Immunol Lett; 1992 Sep; 34(1):45-55. PubMed ID: 1362185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of phorbol ester and interferon-alpha: target cell class I HLA antigen expression and resistance to natural killer and lymphokine-activated killer cell-mediated cytolysis.
    Migita K; Eguchi K; Akiguchi I; Ida H; Kawakami A; Ueki Y; Kurata A; Fukuda T; Nagataki S
    Cell Immunol; 1991 May; 134(2):325-35. PubMed ID: 2021973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid rafts as the signaling scaffold for NK cell activation: tyrosine phosphorylation and association of LAT with phosphatidylinositol 3-kinase and phospholipase C-gamma following CD2 stimulation.
    Inoue H; Miyaji M; Kosugi A; Nagafuku M; Okazaki T; Mimori T; Amakawa R; Fukuhara S; Domae N; Bloom ET; Umehara H
    Eur J Immunol; 2002 Aug; 32(8):2188-98. PubMed ID: 12209631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc gamma receptor signal transduction in natural killer cells. Coupling to phospholipase C via a G protein-independent, but tyrosine kinase-dependent pathway.
    Ting AT; Einspahr KJ; Abraham RT; Leibson PJ
    J Immunol; 1991 Nov; 147(9):3122-7. PubMed ID: 1833464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential interaction of a novel tumor surface protein (p38.5) with naive natural killer cells.
    Das B; Mondragon MO; Tao SZ; Norin AJ
    J Exp Med; 1997 May; 185(10):1735-42. PubMed ID: 9151698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity.
    Zarcone D; Tilden AB; Friedman HM; Grossi CE
    Cancer Res; 1987 May; 47(10):2674-82. PubMed ID: 2436754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms involved in NK resistance induced by interferon-gamma.
    Ramirez R; Solana R; Carracedo J; Alonso MC; Peña J
    Cell Immunol; 1992 Mar; 140(1):248-56. PubMed ID: 1739986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.